Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
However, these mostly depend on a stabilized supply-chain of GLP-1 production, further development of the medication into a potential pill format, expanded health insurance coverage (including Medicare), FDA approval for obesity treatment specifically, and decreasing costs of GLP-1s
Personalized GLP-1 Therapy and Genetic Insights The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, FTO, and MC4R variants that relate to GLP-1 and related signaling pathways
Insurance coverage often differs substantially: Medicare Part D covers Mounjaro for T2D but, as of 2026, does not generally cover Zepbound for weight management
What test results do not show in MyChart
US$ 21.14
US$ 22.57
US$ 25.00
US$ 25.02
